A novel nonsense mutation in the Pit-1 gene: Evidence for a gene dosage effect

Yukiko Hashimoto, Mariangela Cisternino, Laurie E. Cohen

Research output: Contribution to journalArticlepeer-review

Abstract

The POU transcription factor Pit-1 functions in the development of somatotrophs, lactotrophs, and thyrotrophs of the anterior pituitary gland. It also plays a role in cell-specific gene expression and regulation of the gene products from these cell types, GH, prolactin, and TSH, respectively. In the present report we studied a patient with severe growth failure. Provocative studies revealed undetectable GH, prolactin, and TSH levels, and her pituitary gland was hypoplastic on magnetic resonance imaging. She had a novel homozygous nonsense mutation in the 3′ end of the first α-helix of the POU-specific domain of the Pit-1 gene. This mutation results in a truncated protein with loss of most of the Pit-1 DNA-binding domains. Interestingly, her parents, who each have one mutant allele, have evidence of mild endocrine dysfunction. Thus, two normal copies of the Pit-1 gene appear necessary for full Pit-1 gene function.

Original languageEnglish
Pages (from-to)1241-1247
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume88
Issue number3
DOIs
Publication statusPublished - Mar 1 2003

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'A novel nonsense mutation in the Pit-1 gene: Evidence for a gene dosage effect'. Together they form a unique fingerprint.

Cite this